HAYA Therapeutics
$63.1M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
HAYA Therapeutics is currently valued at $115.5M as of April 25, 2025. The company has raised a total of $101.0M in funding.
Capital Efficiency
With a capital efficiency ratio of 1.14x, HAYA Therapeutics has achieved a valuation that is 1.14 times the total capital raised. This metric indicates room for improvement in capital deployment.
Investment Perspective
HAYA Therapeutics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is HAYA Therapeutics Worth in 2025?
As of 2025, HAYA Therapeutics is valued at $115.5M, based on the company's Later Stage VC funding round in April 25, 2025. This valuation positions HAYA Therapeutics as one of the leading private companies in the sector.
HAYA Therapeutics Valuation History
HAYA Therapeutics's funding history demonstrates steady growth and investor confidence.
How HAYA Therapeutics Valuation is Determined
Private company valuations like HAYA Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
HAYA Therapeutics Valuation FAQs
Is HAYA Therapeutics profitable?
HAYA Therapeutics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does HAYA Therapeutics's valuation compare to competitors?
HAYA Therapeutics is valued at $115.5M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will HAYA Therapeutics IPO?
HAYA Therapeutics has not announced plans for an initial public offering. Until an IPO, investors can access HAYA Therapeutics shares through secondary market platforms.